BAUDAX BIO INC - COM (BXRX)

CUSIP: 07160F107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
4,350,660
Share change
-2,223,013
Total reported value
$18,053,000
Put/Call ratio
3.1%
Price per share
$4.15
Number of holders
41
Value change
-$5,265,821
Number of buys
22
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 07160F107?
CUSIP 07160F107 identifies BXRX - BAUDAX BIO INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BAUDAX BIO INC - COM (BXRX) as of Q2 2020

As of 30 Jun 2020, BAUDAX BIO INC - COM (BXRX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,350,660 shares. The largest 10 holders included NORTH RUN CAPITAL, LP, CORSAIR CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Brandywine Global Investment Management, LLC, BlackRock Inc., COMMONWEALTH EQUITY SERVICES, LLC, OBERWEIS ASSET MANAGEMENT INC/, and Ikarian Capital, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.